Experimental medicine approaches to drug development in anxiety disorders
Experimental medicine approaches to drug development in anxiety disorders
Numerous pharmacological and psychological approaches are efficacious in patients with generalized anxiety disorder (GAD) and social anxiety disorder (SAD), though some patients do not respond to treatment and others relapse despite continuing with interventions that were initially beneficial. Other patients respond but stop treatment because of unwanted effects including sexual dysfunction, emotional blunting and weight gain. There is much need for novel interventions with greater overall effectiveness and enhanced acceptability when compared to current treatments, or with particular effectiveness in specific patient groups.
‘Experimental medicine’ studies conducted in healthy subjects provide a ‘proof-of-concept’ approach for determining whether to progress to pivotal efficacy studies, thereby potentially reducing delays in translating innovations into clinical practice. Examples of such studies include inhalation of air ‘enriched’ with 7.5% carbon dioxide, which mirrors the subjective, autonomic and cognitive features of GAD, and administration of testosterone or oxytocin, which respectively target the social avoidance and emotion processing biases of SAD.
experimental medicine, , translation, carbon dioxide inhalation, testosterone, oxytocin, pharmacotherapy, generalized anxiety disorder, social anxiety disorder
Baldwin, David Stewart
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Ayman, Abou-Aisha
514d9775-8070-485f-b59d-84b4a23c0d56
1 September 2018
Baldwin, David Stewart
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Ayman, Abou-Aisha
514d9775-8070-485f-b59d-84b4a23c0d56
Baldwin, David Stewart and Ayman, Abou-Aisha
(2018)
Experimental medicine approaches to drug development in anxiety disorders.
In,
Nomikos, George and Feltner, Doug
(eds.)
Translational Medicine in CNS Drug Development : Handbook of Behavioral Neuroscience.
Elsevier.
Record type:
Book Section
Abstract
Numerous pharmacological and psychological approaches are efficacious in patients with generalized anxiety disorder (GAD) and social anxiety disorder (SAD), though some patients do not respond to treatment and others relapse despite continuing with interventions that were initially beneficial. Other patients respond but stop treatment because of unwanted effects including sexual dysfunction, emotional blunting and weight gain. There is much need for novel interventions with greater overall effectiveness and enhanced acceptability when compared to current treatments, or with particular effectiveness in specific patient groups.
‘Experimental medicine’ studies conducted in healthy subjects provide a ‘proof-of-concept’ approach for determining whether to progress to pivotal efficacy studies, thereby potentially reducing delays in translating innovations into clinical practice. Examples of such studies include inhalation of air ‘enriched’ with 7.5% carbon dioxide, which mirrors the subjective, autonomic and cognitive features of GAD, and administration of testosterone or oxytocin, which respectively target the social avoidance and emotion processing biases of SAD.
Text
Baldwin-AbouAisha-060218
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 1 February 2018
Published date: 1 September 2018
Keywords:
experimental medicine, , translation, carbon dioxide inhalation, testosterone, oxytocin, pharmacotherapy, generalized anxiety disorder, social anxiety disorder
Identifiers
Local EPrints ID: 418284
URI: http://eprints.soton.ac.uk/id/eprint/418284
PURE UUID: 86d8d6c7-a67a-4c1e-b236-a0c3ce3ee73a
Catalogue record
Date deposited: 27 Feb 2018 17:30
Last modified: 16 Mar 2024 02:49
Export record
Contributors
Author:
Abou-Aisha Ayman
Editor:
George Nomikos
Editor:
Doug Feltner
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
